Jireh BioPath is an R&D-driven biotechnology company focused on antiviral drug development. We aim to build a broad-spectrum therapeutic platform for infectious and inflammatory diseases through first-in-class therapeutics targeting innate immune sensors.
We also provide integrated preclinical CRO services spanning histopathology, cell-based assays, and animal studies, supporting our clients throughout the research and preclinical drug development process.



